Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting

Share Article

A group of nine authors involved with TransCelerate BioPharma Inc. will be honored with a Global Inspire Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award program recognizes the organization’s outstanding volunteers for their leadership, level of excellence, and commitment to service on a global scale.

DIA Logo

DIA

“TransCelerate’s efforts to take the lead on improving this process, using its unique structure that unites biopharmaceutical companies across the world in mutual efforts to advance science, is an important model in our industry.”

A group of nine authors involved with TransCelerate BioPharma Inc. will be honored with a Global Inspire Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award program recognizes the organization’s outstanding volunteers for their leadership, level of excellence, and commitment to service on a global scale.

The recipients of the Author(s) of the Year Award, which acknowledges an author or group of authors whose article has made a significant impact in advancing medical product development, published “Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma's Approach, Part 1,” in DIA’s official, scientific, peer-reviewed journal, Therapeutic Innovation & Regulatory Science. This award will recognize their published article as the most widely read article of the DIA publications in 2014.

The article provides a description of how companies are deploying central monitoring in clinical trial quality management and provides samples of the workflows that illustrate how some have implemented it. The paper describes the initial implementation steps designed to learn what organizational capabilities are necessary.

“Improving clinical trial quality management is essential to ensure we have the best and most accurate data emerging from clinical trials as possible,” said Barbara Lopez Kunz, DIA global chief executive. “TransCelerate’s efforts to take the lead on improving this process, using its unique structure that unites biopharmaceutical companies across the world in mutual efforts to advance science, is an important model in our industry.”

Brett Wilson, BSP, Associate Director, Bristol-Myers Squibb Company and Andy Lawton, ASTAT, Global Head, Clinical Management, Boehringer Ingelheim, Ltd. will accept the award on behalf of the article authors.

Additional author winners include: Tom Provencher, BS, Senior Director, Clinical Trial Support and Compliance, UCB Pharma.; Jacqueline Gough, MMath, Central Monitoring, Clinical Development Innovation, Eli Lilly and Company; Stephanie Clark, MA, Research Officer/Board Member, ADHD-Europe, Janssen Pharmaceutical Companies; Ramil Abdrashitov, MD, PhD, MBA, Site Management and Monitoring, Clinical Operations, Global Medicines Development, AstraZeneca; Karolien de Roeck, MS, Clinical Director, AbbVie; Sarah Jane Constantine, MS, Senior Manager, Clinical Trial Oversight and Compliance, Cubist Pharmaceuticals; and David Knepper, MS, MBA, Quality Management Systems & Training, Actavis.

TransCelerate BioPharma Inc., launched in 2012, collaborates across the biopharmaceutical research and development community to identify, prioritize, design and facilitate the implementation of solutions to drive efficient, effective and high-quality delivery of new medicines, improving the health of people around the world. For more information about TransCelerate, click here.

For more information about DIA’s Inspire Award program, click here.

About DIA
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.

DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, Africa and the Middle East (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan). For more information, visit our website at http://www.DIAGlobal.org or contact us via Twitter @DrugInfoAssn, LinkedIn or on Facebook.

About DIA’s 2015 Annual Meeting
The DIA 2015 51st Annual Meeting brings together a 7,000+ community of life sciences professionals at all levels and across all disciplines from around the globe that are involved in the discovery, development and life cycle management of medical products. Follow Annual Meeting news on Twitter using #DIA2015.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Melissa Warren
inVentiv Health
+1 (202) 609-6010
Email >
DrugInfoAssn
Like >
Visit website